Endocrine, Metabolic & Immune Disorders - Drug Targets
Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
5 Year Impact Factor: 1.821
Ranking and Category
134th of 145 in
Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 2 - Number 2
Recombinant Adenovirus-mediated Cytotoxic Gene Therapy and Lymphoproliferative Disorders: Analysis Based on Pharmacodynamics
, 2(2): 109 - 118
Francesco Turturro
View Abstract Permissions Order Reprints Order Eprints
Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes
Nicolas Musi and Laurie J. Goodyear
DOI: 10.2174/1568005310202020119
Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic β Cell Function: Potential Therapeutic Implications
A. Kowluru and R. Amin
Novel Targets for Therapy in Paediatric Oncology
E. J. Estlin
Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia
M. C. Sugden and M. J. Holness
Molecular Basis of Hyperparathyroidism and Potential Targets for Drug Development
L. J. Krebs and A. Arnold
Apoptotic Cell Death in Renal Injury: The Rationale for Intervention
A. Ortiz, P. Justo, M. P. catalan, A. B. Sanz, C. Lorz and J. Egido
Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari "Aldo Moro"
Biography of Emilio Jirillo
Emilio Jirillo is full professor of Immunology at University of Bari Medical School (Bari, Italy) since 1986.His current fields of interest are: mucosal immunity, microbial immunity and immunonutrition. Especially in this last field, he has recently published in vitro and in vivo studies on the anti-inflammatory effects of polyphenols. He is author of more than 560 papers (326 scientific papers are listed in PUBMED), even including books and chapters of books. He is also editor-in-chief- of another Bentham journal: Clinical Immunology Endocrine Metabolic Drugs.
Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Immune Response to Parasitic Infections: Immunity to Helminths and Novel Therapeutic Approaches
Para-Nonylphenol Induces Apoptosis of U937 Human Monocyte Leukemia Cells in vitro, 2016: 16(3); 213 - 223
Kazuki Santa, Tomonori Ohsawa and Takehiko Sakimoto.
View Abstract Rights and Permissions